Clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics called engineered toxin bodies (ETBs).

Clinical-stage biopharmaceutical company developing next-generation, systemically active viral immunotherapies for cancer.

Clinical stage biotechnology company developing therapeutics targeting stress support pathways.

Clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment.

Dedicated to creating life-changing T Cell therapies for patients by unleashing the untapped potential of the human immune system.

Commercial-stage biopharmaceutical company developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology.